292 related articles for article (PubMed ID: 26161392)
1. Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Immunosuppressive Microenvironment.
Guo Q; Li J; Lin H
Biomed Res Int; 2015; 2015():261620. PubMed ID: 26161392
[TBL] [Abstract][Full Text] [Related]
2. Advances in Molecular Mechanisms for Traditional Chinese Medicine Actions in Regulating Tumor Immune Responses.
Huang H; Fang J; Fan X; Miyata T; Hu X; Zhang L; Zhang L; Cui Y; Liu Z; Wu X
Front Pharmacol; 2020; 11():1009. PubMed ID: 32733246
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of immunity-enhancing traditional Chinese medicine.
Wang Y; Zhang Q; Chen Y; Liang CL; Liu H; Qiu F; Dai Z
Biomed Pharmacother; 2020 Jan; 121():109570. PubMed ID: 31710893
[TBL] [Abstract][Full Text] [Related]
4. Research Status and Molecular Mechanism of the Traditional Chinese Medicine and Antitumor Therapy Combined Strategy Based on Tumor Microenvironment.
Zhang Y; Lou Y; Wang J; Yu C; Shen W
Front Immunol; 2020; 11():609705. PubMed ID: 33552068
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages in tumor progression and the role of traditional Chinese medicine in regulating TAMs to enhance antitumor effects.
Zhang J; Gao J; Cui J; Wang Y; Jin Y; Zhang D; Lin D; Lin J
Front Immunol; 2022; 13():1026898. PubMed ID: 36311793
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic gene modified cell based cancer vaccines.
Kozłowska A; Mackiewicz J; Mackiewicz A
Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
[TBL] [Abstract][Full Text] [Related]
7. Progress in the Regulation of Immune Cells in the Tumor Microenvironment by Bioactive Compounds of Traditional Chinese Medicine.
Chen Y; Fan W; Zhao Y; Liu M; Hu L; Zhang W
Molecules; 2024 May; 29(10):. PubMed ID: 38792234
[TBL] [Abstract][Full Text] [Related]
8. Pi (Spleen)-deficiency syndrome in tumor microenvironment is the pivotal pathogenesis of colorectal cancer immune escape.
Sun XG; Lin XC; Diao JX; Yu ZL; Li K
Chin J Integr Med; 2016 Oct; 22(10):789-94. PubMed ID: 26556710
[TBL] [Abstract][Full Text] [Related]
9. [Suppressor cells - the basis of the immunopathogenesis of cancer].
Kozlov VA
Vopr Onkol; 2016; 62(3):390-6. PubMed ID: 30462899
[TBL] [Abstract][Full Text] [Related]
10. The Effectiveness of Traditional Chinese Medicine in Treating Malignancies via Regulatory Cell Death Pathways and the Tumor Immune Microenvironment: A Review of Recent Advances.
Fu J; Xie X; Yao H; Xiao H; Li Z; Wang Z; Ju R; Zhao Y; Liu Z; Zhang N
Am J Chin Med; 2024; 52(1):137-160. PubMed ID: 38328830
[TBL] [Abstract][Full Text] [Related]
11. Targeting tumor-associated macrophages by anti-tumor Chinese materia medica.
Pu WL; Sun LK; Gao XM; Rüegg C; Cuendet M; Hottiger MO; Zhou K; Miao L; Zhang YS; Gebauer M
Chin J Integr Med; 2017 Oct; 23(10):723-732. PubMed ID: 28988387
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Microenvironment and Cancer Cells.
Xu J; Song Z; Guo Q; Li J
Biomed Res Int; 2016; 2016():1490738. PubMed ID: 27042656
[TBL] [Abstract][Full Text] [Related]
13. The effect of anti-angiogenic drugs on regulatory T cells in the tumor microenvironment.
Hu C; Jiang X
Biomed Pharmacother; 2017 Apr; 88():134-137. PubMed ID: 28103506
[TBL] [Abstract][Full Text] [Related]
14. [Prevention and treatment of lung cancer by regulating tumor-associated macrophages with traditional Chinese medicine].
Lian YF; Yang HT; Sun Y; Zhang H; Mei X; Feng L; Xia JC
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(8):2000-2009. PubMed ID: 37282890
[TBL] [Abstract][Full Text] [Related]
15. Impact of TCM on Tumor-Infiltrating Myeloid Precursors in the Tumor Microenvironment.
Liu J; Wang Y; Qiu Z; Lv G; Huang X; Lin H; Lin Z; Qu P
Front Cell Dev Biol; 2021; 9():635122. PubMed ID: 33748122
[TBL] [Abstract][Full Text] [Related]
16. Anti-Tumor Effects of Chinese Medicine Compounds by Regulating Immune Cells in Microenvironment.
Chen F; Li J; Wang H; Ba Q
Front Oncol; 2021; 11():746917. PubMed ID: 34722304
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
18. β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses.
Ning Y; Xu D; Zhang X; Bai Y; Ding J; Feng T; Wang S; Xu N; Qian K; Wang Y; Qi C
Int J Cancer; 2016 Jun; 138(11):2713-23. PubMed ID: 26773960
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppression associated with chronic inflammation in the tumor microenvironment.
Wang D; DuBois RN
Carcinogenesis; 2015 Oct; 36(10):1085-93. PubMed ID: 26354776
[TBL] [Abstract][Full Text] [Related]
20. An Adjuvant Micelle-Based Multifunctional Nanosystem for Tumor Immunotherapy by Remodeling Three Types of Immunosuppressive Cells.
Meng S; Du H; Li X; Zheng X; Zhao P; Yuan Z; Huang S; Zhao Y; Dai L
ACS Nano; 2024 Jan; 18(4):3134-3150. PubMed ID: 38236616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
